Luteolin enhances chemosensitivity through GLUT1 Mediated-Nrf2 inhibition in triple-negative breast cancer cells

First Author / 第一作者

Kuen-Jang Tsai

Institution / 單位

E-Da cancer hospital, Kaohsiung, Taiwan

Audio / 音訊檔

Author Group / 作者群

Kuen-Jang Tsai, M.D.1, Chao-Ming Hung, M.D., Ph.D.1, Chin-Chuan Tsai, M.D., Ph.D.2, Hsin-Yi Tsai3, Ming-Wei Lin, Ph.D.3

Author Group Institution/ 作者群單位

1Department of Surgery, E-Da Cancer Hospital, Kaohsiung 82445, Taiwan 2Department of Chinese Medicine, E-Da Cancer Hospital, Kaohsiung 82445, Taiwan 3Department of Medical Research, E-Da Hospital/E-Da Cancer Hospital, Kaohsiung 82445, Taiwan

Category / 主題分類

Basic Research

Keyword / 關鍵字

Luteolin, Chemosensitivity, Triple negative breast cancer

Back to list